What to Watch in the Day Ahead - Friday, April 26
The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US. Thomson One users can register at RT/DAY/US. All times in ET/GMT
A report from the Commerce Department's Bureau of Economic Analysis is likely to show the personal consumption expenditures (PCE) price index likely rose 0.3% in March after a similar rise in the previous month. In the 12 months through March, PCE likely increased 2.6% after advancing 2.5% in February. Excluding the volatile food and energy components, the PCE price index is expected to rise 0.3% in March, following a similar rise in the month before. The so-called core PCE is expected to gain 2.7% on a year-on-year basis. Meanwhile, consumer spending is expected to have eased with a rise of 0.6% in March after jumping 0.8% in the previous month. Personal income likely grew 0.5% in March, following a 0.3% gain in the previous month. Separately, the University of Michigan's final reading on the overall index of consumer sentiment likely came in at 77.9 in April, unchanged from the previous month.
Oil major Exxon is expected to report first-quarter earnings per share of $2.16 compared with $2.79 a year ago on weaker natural gas prices, higher maintenance costs and derivatives, according to data from financial firm LSEG.
Chevron is expected to report lower first-quarter profits than last year due to weaker oil and gas prices and lower production. Investors will look for a full-year outlook and an update on Hess's acquisition.
Also, AbbVie is scheduled to report its first-quarter earnings. Investor focus is expected to be on the erosion of Humira sales and the growth of its newer immunology drugs, Skyrizi and Rinvoq.
Colgate-Palmolive is expected to post a rise in first-quarter revenue, helped by steady demand for its products including oral care and pet nutrition. Investors will look for comments on pricing actions, demand, impact of increasing competition and annual forecasts.
HCA Healthcare is set to report its first-quarter results before markets open. The focus will be on changes to its annual forecast and comments by the largest U.S. for-profit hospital operator on patient admissions and demand for medical procedures.
Phillips 66 is likely to post a profit decline due to weaker margins; however, tight supplies could boost its margins. Investors will look for any commentary on demand and refining operations.
Charter Communications is expected to post a rise in revenue in the first quarter as it sees steady subscriber growth from its rural expansion plans.
Aon will report higher first-quarter results, helped by the company's growing reliance on its reinsurance products and services.
Asset manager T Rowe Price is scheduled to report its first-quarter earnings. Thanks to a rebound in markets, analysts expect its profit to grow.
Software firm Roper Technologies is expected to report a rise in first-quarter revenue helped by strong IT spending by clients.
In Latin America, Brazil's IPCA-15 consumer price index for the first half of April likely rose 0.29%, following a 0.36% gain in the previous period. Annually, the index probably increased 3.86%. Separately, Mexico's national statistics agency is likely to show a surplus in trade at $700 million for the month of March, after posting a deficit of $585 million in the previous month. Meanwhile, Mexico's headline unadjusted unemployment rate is expected at 2.4% in March.
Compiled by Shreya Sabharwal in Bengaluru; Editing by Ravi Prakash Kumar
Relaterade tillgångar
Senaste nytt
Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.
Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.
Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.
